cabozantinib,atezolizumab
roche
['cabo ', 'contact-03', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo']
contact-03 did not show benefit for atezo + cabo vs cabo after prior ici in rcc. important data presented by #asco23 
Genitourinary oncologist @DanaFarber. Opinions are my own.